Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces Together

17 May 2018

Abstract excerpt

Over the past couple of years, human microbiome has received increasing attention as a regulator and predictor of response to the therapies of various diseases. It is speculated that manipulating gut microbiome can modify response to cancer immunotherapies as well. Through this review, we have critically analyzed our current understanding of gut microbiome as a modulator of immunotherapies in lung cancer,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29781826
DOI: 10.1097/cji.0000000000000232

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces TogetherPMID 29781826Read ↗

Gut microbiome in modulating immune checkpoint inhibitorsSemantic proximity Read ↗

Microbiome: A Supportive or a Leading Actor in Lung Cancer?Semantic proximity Read ↗

Gut Microbiota a Novel Source of Biomarkers for Immunotherapy in Non-small Cell Lung Cancer (NSCLC)Semantic proximity Read ↗

Gut Microbiota in Lung Cancer: Where Do We Stand?Semantic proximity Read ↗

Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer—A reviewSemantic proximity Read ↗

New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of DiscoveriesSemantic proximity Read ↗

The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer ImmunotherapySemantic proximity Read ↗

Gut microbiome and cancer immunotherapySemantic proximity Read ↗

The microbiome in the pathogenesis of lung cancerSemantic proximity Read ↗

A review on the role of gut microbiota in immune checkpoint blockade therapy for cancerSemantic proximity Read ↗

Tumor-Associated Microbiome: Where Do We Stand?Semantic proximity Read ↗

Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic targetSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.